Mnam.Bo
MNAM.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. MNAM.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
MNAM.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
MNAM.BO's capital structure is highly leveraged, with total liabilities of ₹150.77 crore and total equity of -₹8.43 crore, resulting in a debt-to-equity ratio of -17.41. The company's liquidity position is mixed, with a current ratio of 22.26, indicating strong short-term liquidity, but a negative net cash position after subtracting total debt, which raises concerns about long-term solvency.
Profitability is weak, with a net income of ₹1.14 crore on revenue of ₹164.79 crore, and a return on assets of 0.8%. The company reported an operating loss of ₹9.75 crore, which is significantly below the median for the Commodity Chemicals industry, where operating margins are typically positive.
The company's revenue is concentrated in a single business segment, as disclosed in its latest financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic downturns or supply chain disruptions.
Growth appears to be under pressure, with no capital expenditure reported and a negative operating income. The company's free cash flow of ₹2.81 crore is insufficient to cover debt servicing costs, suggesting a need for external financing or operational improvements to sustain operations.
Risk factors include a high debt load and negative equity, which could lead to financial distress if cash flow does not improve. The risk assessment indicates a medium liquidity risk and low dilution risk, but the negative net cash position is a red flag for long-term stability.
Recent filings and transcripts do not provide additional insights into strategic initiatives or operational changes, but the absence of capital expenditure and the operating loss suggest the company is in a defensive financial position.
- MNAM.BO is highly leveraged with a negative equity position, raising concerns about long-term solvency.
- The company reported an operating loss of ₹9.75 crore, significantly below the industry median for Commodity Chemicals.
- Free cash flow is insufficient to cover debt obligations, indicating a need for external financing or operational improvements.
- Revenue is concentrated in a single business segment, increasing exposure to regional or sector-specific risks.
- The company has not invested in capital expenditures, suggesting a lack of growth initiatives or financial constraints.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- MNAM.BO Market data — financials · 2026-05-28